ArticlePulmonary therapy2023

Results From a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis.

Mehdi Mirsaeidi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.